Northwestern Mutual Wealth Management Co. Purchases 3,895 Shares of Henry Schein, Inc. $HSIC

Key Points

• Northwestern Mutual Wealth Management Co. significantly increased its stake in Henry Schein, Inc. by purchasing an additional 3,895 shares, raising its holdings by 1,357.1% to a total of 4,182 shares, valued at $286,000.
• Several institutional investors have also adjusted their stakes in Henry Schein, with notable increases from UMB Bank n.a. (23.2%) and Allworth Financial LP (24.5%) in the first quarter.
• Henry Schein's stock has been the subject of multiple research reports, with varied price target adjustments ranging from $75.00 to $78.00, while currently holding an average rating of "Hold" and a price target of $76.67.

Northwestern Mutual Wealth Management Co. lifted its holdings in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 1,357.1% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 4,182 shares of the company's stock after purchasing an additional 3,895 shares during the quarter. Northwestern Mutual Wealth Management Co.'s holdings in Henry Schein were worth $286,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Investment Management Corp VA ADV purchased a new stake in Henry Schein in the 4th quarter valued at about $32,000. Rakuten Securities Inc. purchased a new stake in Henry Schein in the first quarter worth about $34,000. Whittier Trust Co. raised its holdings in Henry Schein by 714.3% in the first quarter. Whittier Trust Co. now owns 798 shares of the company's stock worth $55,000 after buying an additional 700 shares during the last quarter. UMB Bank n.a. grew its stake in shares of Henry Schein by 23.2% in the first quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock worth $73,000 after acquiring an additional 201 shares during the period. Finally, Allworth Financial LP raised its position in Henry Schein by 24.5% in the first quarter. Allworth Financial LP now owns 1,178 shares of the company's stock worth $78,000 after acquiring an additional 232 shares during the period. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Henry Schein Stock Performance

Shares of HSIC traded down $1.56 during mid-day trading on Monday, hitting $67.87. 714,316 shares of the company's stock were exchanged, compared to its average volume of 1,746,952. The stock's 50-day simple moving average is $69.92 and its 200-day simple moving average is $69.68. The firm has a market cap of $8.23 billion, a price-to-earnings ratio of 21.89, a price-to-earnings-growth ratio of 2.29 and a beta of 0.86. Henry Schein, Inc. has a 52 week low of $60.56 and a 52 week high of $82.49. The company has a quick ratio of 0.78, a current ratio of 1.41 and a debt-to-equity ratio of 0.51.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share for the quarter, missing analysts' consensus estimates of $1.19 by ($0.09). The business had revenue of $3.24 billion during the quarter, compared to analyst estimates of $3.22 billion. Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The company's revenue was up 3.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.23 EPS. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. On average, equities research analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current year.

Analyst Ratings Changes

Several research analysts have recently issued reports on the company. Stifel Nicolaus restated a "hold" rating and issued a $75.00 price objective (down from $80.00) on shares of Henry Schein in a research note on Friday, July 25th. Wall Street Zen lowered shares of Henry Schein from a "buy" rating to a "hold" rating in a research report on Sunday. Evercore ISI raised shares of Henry Schein from an "in-line" rating to an "outperform" rating and set a $83.00 price objective for the company in a research note on Tuesday, August 26th. Robert W. Baird restated a "neutral" rating and set a $72.00 price objective (down previously from $82.00) on shares of Henry Schein in a research note on Monday, July 14th. Finally, Barrington Research decreased their target price on shares of Henry Schein from $86.00 to $78.00 and set an "outperform" rating for the company in a research report on Wednesday, August 6th. Five investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $76.67.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.